Thaddeus T. Schug
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thaddeus T. Schug has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Jerrold J. Heindel
National Institute of Environmental Health Sciences/National Institutes of Health (T.T.S., J.J.H.), Division of Extramural Research, Research Triangle Park, North Carolina 27560
5 shared publicationsAnne F. Johnson
MDB, Inc (A.F.J.), Durham, North Carolina 27713
3 shared publications- Xiaoling Li
National Institute of Environmental Health Sciences
3 shared publications Frederick S. Vom Saal
Division of Biological Sciences and Department (F.S.v.S.),University of Missouri-Columbia, Columbia, Missouri 65211
2 shared publications- Linda S. Birnbaum
Nicholas School of the Environment, Duke University, Durham, USA
2 shared publications - Nigel J. Walker
National Institute of Environmental Health Sciences
2 shared publications
Latest Publications
- Open Access
- 1 August 2016
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 30 (8) , 833-847
Minireview: Endocrine Disruptors: Past Lessons and Future Directions
Within the past few decades, the concept of endocrine-disrupting chemicals (EDCs) has risen from a position of total obscurity to become a focus of dialogue, debate, and concern among scientists, physicians, regulators, and the public. The emergence and development of this field of study has not always followed a smooth path, and researchers continue to wrestle with questions about the low-dose effects and nonmonotonic dose responses seen with EDCs, their biological mechanisms of action, the true pervasiveness of these chemicals in our environment and in our bodies, and the extent of their effects on human and wildlife health. This review chronicles the development of the unique, multidisciplinary field of endocrine disruption, highlighting what we have learned about the threat of EDCs and lessons that could be relevant to other fields. It also offers perspectives on the future of the field and opportunities to better protect human health.
- 1 August 2016
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 30 (8) , 833-847
Open AccessMinireview: Endocrine Disruptors: Past Lessons and Future Directions
Within the past few decades, the concept of endocrine-disrupting chemicals (EDCs) has risen from a position of total obscurity to become a focus of dialogue, debate, and concern among scientists, physicians, regulators, and the public. The emergence and development of this field of study has not always followed a smooth path, and researchers continue to wrestle with questions about the low-dose effects and nonmonotonic dose responses seen with EDCs, their biological mechanisms of action, the true pervasiveness of these chemicals in our environment and in our bodies, and the extent of their effects on human and wildlife health. This review chronicles the development of the unique, multidisciplinary field of endocrine disruption, highlighting what we have learned about the threat of EDCs and lessons that could be relevant to other fields. It also offers perspectives on the future of the field and opportunities to better protect human health.
- 1 June 2015
- Published by The Endocrine Society in Endocrinology
- Vol. 156 (6) , 1941-1951
Elucidating the Links Between Endocrine Disruptors and Neurodevelopment
Recent data indicate that approximately 12% of children in the United States are affected by neurodevelopmental disorders, including attention deficit hyperactivity disorder, learning disorders, intellectual disabilities, and autism spectrum disorders. Accumulating evidence indicates a multifactorial etiology for these disorders, with social, physical, genetic susceptibility, nutritional factors, and chemical toxicants acting together to influence risk. Exposure to endocrine-disrupting chemicals during the early stages of life can disrupt normal patterns of development and thus alter brain function and disease susceptibility later in life. This article highlights research efforts and pinpoints approaches that could shed light on the possible associations between environmental chemicals that act on the endocrine system and compromised neurodevelopmental outcomes.
- 1 June 2015
- Published by The Endocrine Society in Endocrinology
- Vol. 156 (6) , 1941-1951
Elucidating the Links Between Endocrine Disruptors and Neurodevelopment
Recent data indicate that approximately 12% of children in the United States are affected by neurodevelopmental disorders, including attention deficit hyperactivity disorder, learning disorders, intellectual disabilities, and autism spectrum disorders. Accumulating evidence indicates a multifactorial etiology for these disorders, with social, physical, genetic susceptibility, nutritional factors, and chemical toxicants acting together to influence risk. Exposure to endocrine-disrupting chemicals during the early stages of life can disrupt normal patterns of development and thus alter brain function and disease susceptibility later in life. This article highlights research efforts and pinpoints approaches that could shed light on the possible associations between environmental chemicals that act on the endocrine system and compromised neurodevelopmental outcomes.
- 1 September 2013
- Published by Elsevier in Reproductive Toxicology
- Vol. 40, 35-40
A new approach to synergize academic and guideline-compliant research: The CLARITY-BPA research program
- 1 September 2013
- Published by Elsevier in Reproductive Toxicology
- Vol. 40, 35-40
A new approach to synergize academic and guideline-compliant research: The CLARITY-BPA research program
- Open Access
- 1 April 2013
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 121 (4) , 410-414
ONE Nano: NIEHS’s Strategic Initiative on the Health and Safety Effects of Engineered Nanomaterials
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences
- 1 April 2013
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 121 (4) , 410-414
Open AccessONE Nano: NIEHS’s Strategic Initiative on the Health and Safety Effects of Engineered Nanomaterials
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences
- 20 December 2012
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1276 (1) , 37-46
Fetal programming and environmental exposures: implications for prenatal care and preterm birth
Sponsored by the New York Academy of Sciences and Cincinnati Children's Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, “Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth” was held on June 11–12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers went on to discuss many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus.
- 20 December 2012
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1276 (1) , 37-46
Fetal programming and environmental exposures: implications for prenatal care and preterm birth
Sponsored by the New York Academy of Sciences and Cincinnati Children's Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, “Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth” was held on June 11–12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers went on to discuss many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus.
- Open Access
The Perfect Storm for Obesity
Obesity rates have risen steadily in the United States and around the world over the past century, with a marked escalation within the past two decades. Conventional wisdom within the medical community is that the burgeoning obesity epidemic is the product of poor nutrition and lack of exercise, but increasingly researchers are questioning whether those factors are wholly responsible. Emerging research about alternative factors is setting the stage for today's “Perfect Storm” for obesity.
Open AccessThe Perfect Storm for Obesity
Obesity rates have risen steadily in the United States and around the world over the past century, with a marked escalation within the past two decades. Conventional wisdom within the medical community is that the burgeoning obesity epidemic is the product of poor nutrition and lack of exercise, but increasingly researchers are questioning whether those factors are wholly responsible. Emerging research about alternative factors is setting the stage for today's “Perfect Storm” for obesity.
- 5 September 2012
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 131 (2) , 343-350
PPTOX III: Environmental Stressors in the Developmental Origins of Disease--Evidence and Mechanisms
Fetal and early postnatal development constitutes the most vulnerable time period of human life in regard to adverse effects of environmental hazards. Subtle effects during development can lead to functional deficits and increased disease risk later in life. The hypothesis stating that environmental exposures leads to altered programming and, thereby, to increased susceptibility to disease or dysfunction later in life has garnered much support from both experimental and epidemiological studies. Similar observations have been made on the long-term impact of nutritional unbalance during early development. In an effort to bridge the fields of nutritional and environmental developmental toxicity, the Society of Toxicology sponsored this work. This report summarizes novel findings in developmental toxicity as reported by select invited experts and meeting attendees. Recommendations for the application and improvement of current and future research efforts are also presented.
- 5 September 2012
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 131 (2) , 343-350
PPTOX III: Environmental Stressors in the Developmental Origins of Disease--Evidence and Mechanisms
Fetal and early postnatal development constitutes the most vulnerable time period of human life in regard to adverse effects of environmental hazards. Subtle effects during development can lead to functional deficits and increased disease risk later in life. The hypothesis stating that environmental exposures leads to altered programming and, thereby, to increased susceptibility to disease or dysfunction later in life has garnered much support from both experimental and epidemiological studies. Similar observations have been made on the long-term impact of nutritional unbalance during early development. In an effort to bridge the fields of nutritional and environmental developmental toxicity, the Society of Toxicology sponsored this work. This report summarizes novel findings in developmental toxicity as reported by select invited experts and meeting attendees. Recommendations for the application and improvement of current and future research efforts are also presented.
- Top Cited Papers
- 1 November 2011
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 127 (3-5) , 204-215
Endocrine disrupting chemicals and disease susceptibility
- 1 November 2011
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 127 (3-5) , 204-215
Top Cited PapersEndocrine disrupting chemicals and disease susceptibility
- Open Access
- 28 February 2011
- Published by Impact Journals, LLC in Oncotarget
- Vol. 2 (1-2) , 5-7
Targeting Transcription Through Inhibition of TBP
Targeting Transcription Through Inhibition of TBP
- 28 February 2011
- Published by Impact Journals, LLC in Oncotarget
- Vol. 2 (1-2) , 5-7
Open AccessTargeting Transcription Through Inhibition of TBP
Targeting Transcription Through Inhibition of TBP
- 24 February 2011
- Published by Taylor & Francis in Annals of Medicine
- Vol. 43 (3) , 198-211
Sirtuin 1 in lipid metabolism and obesity
Sirtuin 1 (SIRT1), the mammalian ortholog of yeast Sir2, is a highly conserved NAD+-dependent protein deacetylase that has emerged as a key metabolic sensor that directly links environmental nutrient signals to animal metabolic homeostasis. SIRT1 is known to be involved in gluconeogenesis in the liver, fat mobilization in white adipose tissue, and insulin secretion in the pancreas. Recent studies have shown SIRT1 to regulate fatty acid oxidation in the liver, sense nutrient availability in the hypothalamus, influence obesity-induced inflammation in macrophages, and modulate the activity of the circadian clock in metabolic tissues. The activity of SIRT1 also appears to be under the control of AMPK and adiponectin. This review focuses on the involvement of SIRT1 in regulating metabolic diseases associated with obesity. It includes brief overviews of sirtuin signaling, with emphasis on SIRT1's role in the liver, macrophage, brain, and adipose tissue as it relates to obesity.
- 24 February 2011
- Published by Taylor & Francis in Annals of Medicine
- Vol. 43 (3) , 198-211
Sirtuin 1 in lipid metabolism and obesity
Sirtuin 1 (SIRT1), the mammalian ortholog of yeast Sir2, is a highly conserved NAD+-dependent protein deacetylase that has emerged as a key metabolic sensor that directly links environmental nutrient signals to animal metabolic homeostasis. SIRT1 is known to be involved in gluconeogenesis in the liver, fat mobilization in white adipose tissue, and insulin secretion in the pancreas. Recent studies have shown SIRT1 to regulate fatty acid oxidation in the liver, sense nutrient availability in the hypothalamus, influence obesity-induced inflammation in macrophages, and modulate the activity of the circadian clock in metabolic tissues. The activity of SIRT1 also appears to be under the control of AMPK and adiponectin. This review focuses on the involvement of SIRT1 in regulating metabolic diseases associated with obesity. It includes brief overviews of sirtuin signaling, with emphasis on SIRT1's role in the liver, macrophage, brain, and adipose tissue as it relates to obesity.